News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Honoring the many lived experiences with Long COVID
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Feature
11 Results
11 Results
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
R3 Seminar Recap: Using RECOVER data to advance your research
On December 9, 2025, the RECOVER Initiative hosted the first webinar in a two-part series to help researchers use data from the initiative’s observational studies to advance Long COVID research. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
RECOVER’s tissue pathology (autopsy) study makes unique contributions to Long COVID research
Using a large and diverse collection of tissue samples, experts in how diseases affect different parts of the body will explore the underlying causes of Long COVID.
Feature
Long COVID clinic provides access to research studies and care for University of New Mexico patients
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Feature
RECOVER researchers publish pediatric study design
The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Announcement